SCHEMBL52747

SCHEMBL52747

CC(O)C(C)C(N)C(=O)O

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC7A5 Q01650 2/20 0.57
TP53 P04637 1/20 0.45
SLC1A3 P43003 3/20 0.42
SLC1A2 P43004 3/20 0.42
SLC1A1 P43005 2/20 0.42
USP2 O75604 1/20 0.39
SLCO1B1 Q9Y6L6 1/20 0.39
GABRP O00591 3/20 0.33
GABRD O14764 3/20 0.33
GABRA1 P14867 3/20 0.33
GABRB1 P18505 3/20 0.33
GABRG2 P18507 3/20 0.33
GABRB3 P28472 3/20 0.33
GABRA5 P31644 3/20 0.33
GABRA3 P34903 3/20 0.33
GABRA2 P47869 3/20 0.33
GABRB2 P47870 3/20 0.33
GABRA4 P48169 3/20 0.33
GABRE P78334 3/20 0.33
GABRA6 Q16445 3/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14420268 1.00 SLC7A5 (0.57) SLC7A5TP53SLC1A3SLC1A2SLC1A1
SCHEMBL14420361 1.00 SLC7A5 (0.57) SLC7A5TP53SLC1A3SLC1A2SLC1A1
SCHEMBL598013 1.00 SLC7A5 (0.57) SLC7A5TP53SLC1A3SLC1A2SLC1A1
SCHEMBL52746 1.00 SLC7A5 (0.57) SLC7A5TP53SLC1A3SLC1A2SLC1A1
SCHEMBL13502497 1.00 SLC7A5 (0.57) SLC7A5TP53SLC1A3SLC1A2SLC1A1
SCHEMBL13502491 1.00 SLC7A5 (0.57) SLC7A5TP53SLC1A3SLC1A2SLC1A1
SCHEMBL5516743 1.00 SLC7A5 (0.57) SLC7A5TP53SLC1A3SLC1A2SLC1A1
SCHEMBL4965400 1.00 SLC7A5 (0.57) SLC7A5TP53SLC1A3SLC1A2SLC1A1
SCHEMBL3574366 1.00 SLC7A5 (0.57) SLC7A5TP53SLC1A3SLC1A2SLC1A1
SCHEMBL599279 1.00 SLC7A5 (0.57) SLC7A5TP53SLC1A3SLC1A2SLC1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1485 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116549428-B New application of 4-hydroxyisoleucine 郑州大学 2025-05-16 CN claimed
CN-119775234-A Compound with plant growth regulation effect and preparation method and application thereof 北京中医药大学 2025-04-08 CN claimed
CN-119745855-A Application of alpha-ketoglutarate substance in preparation of medicine for treating fetal intrauterine growth restriction 安徽医科大学 2025-04-04 CN claimed
CN-119454684-A Application of 4-hydroxyisoleucine in preparation of medicine for treating atherosclerosis 杨朝晖 2025-02-18 CN claimed
CN-118125936-A N-acyl ethanolamide derivative, preparation method and application thereof 南京清普生物科技有限公司 2024-06-04 CN claimed
CN-117866861-A Genetically engineered bacterium for producing 4-hydroxyisoleucine and application thereof 无锡晶海氨基酸股份有限公司 2024-04-12 CN claimed
CN-117388421-A Method for identifying forage grass rhizosphere secretion and differential metabolite thereof based on non-targeted metabonomics 中国农业大学 2024-01-12 CN claimed
CN-116870038-A Post-natal powder of lactobacillus plantarum J26 and application of post-natal powder in aspect of cholesterol reduction 东北农业大学 2023-10-13 CN claimed
CN-114480466-B Dynamic regulation bacterium for producing 4-hydroxyisoleucine and application thereof 江南大学 2023-08-25 CN claimed
CN-116549428-A New application of 4-hydroxyisoleucine 郑州大学 2023-08-08 CN claimed
CN-1397545-A A method for extracting 4-hydroxy-isoleucine and fenugreek gum from semen Trigonellae YINGHAN INTERNAT TRADE CO LTD (CN) 2003-02-19 CN claimed
EP-1053232-B1 PROCESS FOR THE PREPARATION OF SOTOLON UNILEVER NV (NL) 2002-11-06 EP claimed
CN-1376062-A Use of amino acids for making medicine for treating to insulin-resistance INNODIA S A (FR) 2002-10-23 CN claimed
EP-1206257-A1 USE OF AMINO ACIDS FOR MAKING MEDICINES FOR TREATING INSULIN-RESISTANCE Innodia (FR) 2002-05-22 EP claimed
CN-1289329-A Process for preparing SOTOLON UNILEVER NV (NL) 2001-03-28 CN claimed
WO-2001015689-A1 USE OF AMINO ACIDS FOR MAKING MEDICINES FOR TREATING TO INSULIN-RESISTANCE CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) 2001-03-08 WO claimed
EP-0587476-B1 Compositions containing mono or polyhydroxylated amino acids for the treatment of non-insulin dependent diabetes mellitus JOUVENET SOC CIV (FR) 1998-03-18 EP claimed
WO-1997032577-A1 ANTIDIABETIC COMPOSITION CONTAINING (2S, 3R, 4S)4-HYDROXYISOLEUCINE SOCIETE CIVILE DE GESTION JOUVENET (FR) 1997-09-12 WO claimed
US-5470879-A 4-hydroxyisoleucine or lactone thereof LABORATORIES MONAL (FR) 1995-11-28 US claimed
EP-0587476-A1 Compositions containing mono or polyhydroxylated amino acids for the treatment of non-insulin dependent diabetes mellitus Société Civile JOUVENET (FR) 1994-03-16 EP claimed